✦ LIBER ✦

5048 A Q-TWiST analysis of lapatinib plus letrozole compared with letrozole alone as first-line therapy in hormone receptor positive (HR+) metastatic breast cancer (MBC)

✍ Scribed by B. Sherrill; M. Amonkar; B. Sherif; J. Maltzman; L. O'Rourke; S. Johnston

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN15 SYSTEMATIC REVIEW OF LAPATINIB PLU

✍ R Riemsma; CA Forbes; M Amonkar; K Lykopoulos; JR Diaz; J Kleijnen; DW Rea 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

Systematic review of lapatinib in combin

✍ Riemsma, Rob; Forbes, Carol A.; Amonkar, Mayur M.; Lykopoulos, Konstantinos; Dia 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 385 KB

Quality-adjusted survival analysis of fi

✍ Sherrill, Beth; Sherif, Bintu; Amonkar, Mayur M.; Maltzman, Julie; O’Rourke, Lis 📂 Article 📅 2011 🏛 Informa plc 🌐 English ⚖ 497 KB

PCN105 PATIENT PREFERENCE-BASED UTILITY

✍ TE Delea; O Sofrygin; M Amonkar 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB

Higher efficacy of letrozole in combinat

✍ J. Huober; P.A. Fasching; M. Barsoum; L. Petruzelka; D. Wallwiener; C. Thomssen; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 350 KB

PCN97 A COST-UTILITY ANALYSIS ON THE USE

✍ S McNamara; L Moore; J Ray 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB